| Old Articles: <Older 46201-46210 Newer> |
|---|
 |
The Motley Fool
December 27, 2010
Amanda B. Kish |
Why Even Bond Managers Hate Bonds It may be time to switch back to stocks.   |
The Motley Fool
December 27, 2010
Brian D. Pacampara |
BioSante Pharmaceuticals Shares Popped: What You Need to Know Shares of BioSante Pharmaceuticals, which develops products for female sexual health and oncology, soared a staggering 28% in intraday trading on extraordinarily high volume. |
The Motley Fool
December 27, 2010
Brian Orelli |
FDA Kicks Dust on Alimera's Fairy Tale Eight months after its IPO, Alimera gets hammered. |
The Motley Fool
December 27, 2010
Andrew Bond |
A Footwear Giant That Doesn't Fake It Instead of entering the toning shoe market, Nike has transformed it. |
The Motley Fool
December 27, 2010
Andrew Bond |
PayPal Is Still eBay's Crown Jewel Even with recent e-commerce acquisitions, eBay's payments platform is an engine of growth. |
The Motley Fool
December 27, 2010
Anders Bylund |
TiVo's Significant Role in 2011 TiVo's glory days lie ahead -- followed by darker times. |
The Motley Fool
December 27, 2010
Travis Hoium |
Sporting Stocks to Avoid in 2011 Sporting goods have made a comeback, but golf is being left behind. |
The Motley Fool
December 27, 2010
Tim Beyers |
Scrooge Finally Slips Up No stock screen is perfect, but this one generates a list of stocks that cautiously greedy investors may wish to consider for the year ahead. Last |
The Motley Fool
December 27, 2010
Matt Koppenheffer |
4 Troublesome Investing Myths Start off 2011 on the right foot -- without these four equity investing myths holding you back. |
The Motley Fool
December 27, 2010
John Reeves |
Our Top Picks and Stock Pickers The socially responsible investor takes the lead. |
| <Older 46201-46210 Newer> Return to current articles. |
